Wheatley M, Strange P G
FEBS Lett. 1983 Jan 10;151(1):97-101. doi: 10.1016/0014-5793(83)80351-2.
Brain D2 dopamine receptors have been solubilised using lysophosphatidylcholine. The inclusion of proteinase inhibitors during solubilisation enables a preparation to be obtained containing a high proportion of solubilised D2 receptors with pharmacological properties similar to those of membrane-bound D2 receptors.
已使用溶血磷脂酰胆碱将脑 D2 多巴胺受体溶解。在溶解过程中加入蛋白酶抑制剂能够获得一种制剂，该制剂含有高比例的具有与膜结合 D2 受体相似药理学特性的溶解 D2 受体。
